Fuqiang Zhao

November 21, 2024

Pan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer

Abstract Background/Objectives: Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (PLOD1) is known as an enhancer of collagen fiber deposition and cross-linking stability. However,…

July 28, 2023

GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer

Abstract Background: Basal-like breast cancer (BLBC) takes up about 10–20% of all breast cancer(BC), what’s more, BLBC has the lowest…

March 21, 2022

Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance

Abstract Background: Necroptosis is a novel programmed cell death mode independent on caspase. A number of studies have revealed that…